Clinical Trials
5 trialsNCT05036291 2026-04-22
A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors
Ningbo Newbay Technology Development Co., Ltd
Phase 1 Terminated
NCT04892017 2026-04-08
Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors
Deciphera Pharmaceuticals, LLC
Phase 1 Terminated
NCT05313009 2025-12-16
Tarlox and Sotorasib in Patients With KRAS G12C Mutations
Medical University of South Carolina
Phase 1/2 Terminated
NCT05374538 2025-05-01
VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer
Vitrac Therapeutics, LLC
Phase 1 Terminated
NCT05480865 2024-12-12
Argonaut
Navire Pharma Inc., a BridgeBio company
Phase 1 Terminated